Connect with us

Women’s Health

The Covid Vaccine May Affect Your Period — But No, It Doesn’t Cause Infertility

Published

on

A friend texted last week, concerned that the Covid vaccine made her do it barren. Her period was late, she said, and others had (anecdotally) reported the same thing on Twitter. While technically I could relate to it – I also had strange period symptoms after myself – I was shocked at the jump from irregular periods to full-fledged pregnancy problems. I hadn’t noticed yet that there were rumors floating around about Reddit and other anti-Vaxxer platforms claiming this Iinfertility and miscarriages are unreported side effects of the vaccines.

The key word there is of course “rumors”. Like much of the ongoing and problematic debate about vaccines, these claims are completely false and unfounded.

More from SheKnows

Even so, fictional gossip can be compelling, as evidenced by my friend’s panicked lyrics as well as the most recent ones Mira fertility study: 68 percent of Mira customers are still hesitant about the vaccines and suspect that they “cause fertility problems”. It is worth noting, however, that only 20 percent of those surveyed have actually consulted a doctor or gynecologist about the vaccination. It is therefore unclear where this fear originally came from.

The fact is: science shows that the Vaccine is safe and effective – and does not affect fertility. Still, if you have concerns, we interviewed several reproductive health experts on the topic to allay your concerns.

Click here to read the full article.

“There is absolutely no clinical evidence or proven theories about how vaccines would cause infertility,” says Dr. Kelly Culwell, MD, a scholarship-trained gynecologist who previously worked with the World Health Organization and Intended Parenthood. “All major women’s health organizations – including the American Society for Reproductive Medicine [(ASRM)], a group made up of infertility experts, agree that there is no evidence to support these concerns. “

The story goes on

It’s true: ASRM Emphasizes that “COVID-19 vaccination is recommended for women contemplating pregnancy or for women who are pregnant in order to minimize the risk to themselves and their pregnancy.” These guidelines are in line with those of the US Advisory Committee on Immunization Practices Center for Disease Control and Prevention and the American College of Obstetricians and Gynecologists.

And so it is with all Vaccines, not just those that help prevent Covid.

“There is no comparable case in which a vaccine has caused infertility or miscarriages,” says Dr. Amy Roskin, MD, Chartered Gynecologist and Medical Director of The pill club. “In general, vaccines protect against diseases that are a higher risk for pregnant women.”

If you’re worried that technically it didn’t special investigated in clinical trials with COVID vaccines, Dr. Cary L. Dicken, MD, FACOG, a reproductive endocrinologist and infertility specialist RMA Long Island IVFhas an insight. “No fertility loss was reported in the study participants or in the millions who have received the vaccines,” she said. “In addition, there were no signs of infertility in animal experiments. Due to the way the vaccine works, fertility loss is unlikely. “

Also, many pregnant people in the US have received the vaccines and their pregnancies are unaffected. “The data collected did not predict any safety concerns for pregnant people,” she continues. “Pregnancy and neonatal outcomes for 827 completed pregnancies have been reported in the United States New England Journal of Medicine and [there was] no increased risk of miscarriages, [or] Pregnancy complication. “

In addition, the ability to get pregnant and / or lose suddenly doesn’t really work that way. It’s not something anyone can do root cause in normal everyday life – unless there is one thing for which there is no antidote: time.

“Age is the greatest cause of infertility,” Dr. Taraneh Shirazian, MD, Certified Gynecologist, Director of Global Women’s Health, NYU College of Global Public Health, and Founder of Mom is importantsays. Otherwise there are some technically conditions The can affect people’s ability to ovulate, such as polycystic ovarian syndrome, thyroid disease, uterine polyps, endometriosis, primary ovarian failure (early menopause), and certain forms of cancer. The Mayo Clinic also mentions tobacco and alcohol use as possible factors, although fertility is far more complicated than a list of potential risk factors and really depends on the individual – and not on whether or not they have been vaccinated.

“There is no evidence and no biological plausibility that vaccines would affect fertility …[or] Your reproductive organs, ”claims Shirazian. “Even once you’ve discovered the cycle you were given the vaccine on, it’s considered a common response to external stress.”

Understanding These Menstrual Cycle Side Effects

So these anecdotal accounts of shifts in cycles are Not Cause for concern. In some ways, this is to be expected: anything that affects the immune system, from new drugs to a vaccine to stress, can potentially trigger this side effect.

“There is a lot of scientific evidence for this [the] The endocrine system is very sensitive and can easily be influenced by physical, chemical and emotional stressors. “Dr. Mindy fur, MD, functional medicine and women’s health expert and author of Resetting Menopause explained. “This vaccine could fall into the category of a stressor affecting the ebb and flow of hormones.”

“Any stress on the body or the immune system can potentially cause a temporary delay or change in menstruation,” agrees Culwell. “It is possible that the same will happen with other vaccines. [but] It is a very unusual time when large numbers of people are vaccinated at the same time, which may explain why we hear a group of these reports. “

“There is evidence that a strong immune response can affect your periods,” adds Roskin. “Cells of the immune system are involved in regulating, building and breaking down the lining of the uterus that causes menstrual bleeding.”

Regarding the rumors of pregnancy loss: I also asked about it.

“Miscarriages are unfortunately very common – half of all pregnancies end in a miscarriage – but most people are unaware of it,” says Culwell. “The fact that some women had miscarriages by the time they were given a COVID vaccine leads people to wrong conclusions when it really is just a bad coincidence.”

“The ‘theory’ as to why this is true – that a protein that the vaccine recognizes resembles a protein that is required to establish a pregnancy – has been fully debunked,” she adds.

“The only thing the vaccine can do with regards to reproduction is to protect you from the very serious complications that COVID can cause in pregnancy.”

Every professional – and every large reproductive health organization – spoke to counseled people who are pregnant and / or hoping to receive the vaccine. This applied to all genders, regardless of whether they carry out the pregnancy or not. In fact, the Society for Male Reproduction (SMRU) and the Society for the Study of Male Reproduction (SSMR) have strongly recommended that Dicken says that the vaccine should not be withheld from men hoping to conceive.

“COVID has been shown to cause serious illness and increase complications during pregnancy. Pregnant women are at higher risk of more serious illness, intensive care and hospitalization than non-pregnant women their age [and] should get the vaccine, ”says Shirazia. “An added bonus is that mom’s antibodies also get to the fetus and protect the newborn.”

“There is solid data to suggest that pregnancy is a risk factor for developing a serious illness,” confirms Dicken. “There are currently no data on the adverse effects of the vaccine on a person’s fertility. In my opinion, the benefits of vaccination outweigh any unknown risk. “

“I agree with all professional medical organizations on this point,” concludes Culwell. “The only thing the vaccine can do with regards to reproduction is to protect you from the very serious complications that COVID can cause in pregnancy.”

Before you get started, take a look at some of the different products currently on the market:

Start gallery: Children’s books about COVID-19 help children understand the pandemic at their level

Best of SheKnows

Sign up for the SheKnows newsletter.
Follow us for the latest news on
Facebook,
Twitter and
Instagram.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Women’s Health

Organon announces commitment to accelerating advancements in women’s health at EXPO 2020

Published

on

With a diverse portfolio that includes women’s health, biosimilars and established brands, Organon is the only company in the world that is solely focused on women’s health. Serving 140 markets with 60 drugs and solutions, the healthcare company now operates in the United Arab Emirates, Oman, Kuwait, Qatar, KSA, Egypt, Lebanon, Jordan, Turkey and Ukraine. In line with the UN Sustainable Development Goal for Gender Equality and the Empowerment of Women, Organon’s mission is to improve and innovate health care for women.

Comment on the start, Ramy Koussa, Vice President of Organon MENAT, said: “Our goal is to advance health care for women in MENAT by addressing their unmet needs and helping to build a healthier and better future for all women, families and communities With local authorities and industry stakeholders, we seek to shift the paradigm of women’s health beyond reproductive health and embrace the full life cycle. This forum is an important first for us at Organon MENAT to listen to women and become a trusted partner in the health care of women in the region, “he added.

Topics discussed by the respected women’s health experts included existing data gaps hindering improvements in women’s health, monitoring progress towards the UN Sustainable Development Goal of gender equality, investing in health care and accelerating change through economic growth Strengthening. Panelists present included: Dr Susanne Fiedler, Chief Commercial Officer of Organon; Susanne Michail, Regional Director of the United Nations Unit for Gender Equality and Women’s Empowerment in Arab States; Bathylle Missika, Head of Networks, Partnerships and Gender at the OECD Development Center; Myra Betron, Director of Gender Issues at Jhpeigo; and Dina El– Shenoufy, Chief Investment Officer at Flat6lab.

MS. Susanne Michail, Regional Director of the United Nations Unit for Gender Equality and Women’s Empowerment in Arab States, said: “A better understanding and better management of the unmet health needs of women is essential for achieving the sustainable goals of the 2030 Agenda, including the extremely important gender equality and economic empowerment goals for women. In addition to considering health services as a fundamental right per se, women’s health is also directly related to economic development. For example, women could add $ 28 trillion (or 26% of global GDP) of the world economy by 2025 when their health issues are addressed so they can better participate in the labor market. So it is exciting to see how Organon is focusing on the health needs of women and accelerating advances in women’s health in the region. “

Commentary after the panel discussion, Dr Susanne Fiedler, Organon’s Chief Commercial Officer, said, “At Organon we are working towards a world where every woman can enjoy better health. To this end, we will work closely with industry stakeholders, from private to public organizations, health care providers, Patient societies and others to develop efficient and differentiated operating models to improve the delivery of health services to women across the region. ”

DR Sawsan AS Al Madhi, Director General, Friends of Cancer Patients, added, “Friends of Cancer Patients (FOCP) is a patient-centric organization. We fundamentally believe that the patient must be heard and empowered to ensure the best possible care. We welcome the introduction of Organon across the board middle East, North africa and Turkey Region and look forward to our collaborative approach to better understand and address the unmet health needs of women. “

With a dynamic business model and entrepreneurial approach, and in line with its commitment to accelerating progress in women’s health, the company also launched the Femtech Accelerator Program in the middle East and North africa together with the early-stage venture capital firm Flat6Labs, the result of their first official regional collaboration. Together, the companies will support women-led and focused start-ups in the digital healthcare sector and help them develop a Medium Viable Product (MVP). Selected start-ups take part in a two-month intensive acceleration program with individual coaching and mentoring with relevant leading industry experts, online training and matchmaking with potential technology, investment and business partners.

Copyright © 2021 Organon Group of Companies. All rights reserved. If you need an update, have an inquiry or need to report a side effect, you can contact the following address:

Tel .: +9714 5639700
Fax: +9714 5805629
E-mail: [email protected]

About Organon:

Organon (NYSE: OGN) is a global healthcare company that emerged from a spin-off from Merck and known outside the United States as MSD The United States and Canadato focus on improving women’s health throughout their lives. For your health, the company has a portfolio of more than 60 drugs and products from a number of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and a stable franchise of established drugs, Organon’s products generate strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to work with biopharmaceutical innovators who wish to commercialize their products by leveraging their size and presence in rapidly growing international markets.

Organon has a global presence of significant size and geographic reach, world class commercial capabilities, and approximately 9,000 employees headquartered in Jersey City, New Jersey.

For more information, visit www.organon.com and connect with us on LinkedIn, Instagram and Facebook.

Photo – https://mma.prnewswire.com/media/1671656/Organon.jpg
Logo – https://mma.prnewswire.com/media/1671657/Organon_Logo.jpg

SOURCE Organon

similar links

https://www.organon.com

Continue Reading

Women’s Health

FIGO 2021 World Congress Blog – Day Five

Published

on

Investigation of Controversies in Treatment at the Israel Forum

The fifth day of the FIGO 2021 World Congress began with a session on treatment controversies, which took place live on the Israel Forum and was streamed directly on our virtual platform. During that session there was a fascinating debate about the use of valaciclovir to prevent vertical transmission of cytomegalovirus. Dr. Yacov Amir spoke first, suggesting that valaciclovir was an effective form of treatment, followed by Dr. Rinat Gabbay-Benziv, who argued that it had its limits. The session ended with a panel discussion and questions and answers between the speakers and moderators.

COVID-19 and the women’s health crisis

We then had the honor of enjoying the BN Purandare lecture organized by the Federation of Obstetric and Gynecological Societies of India (FOGSI). Dr. Alpesh Gandhi gave a keynote on the “Women’s Health Crisis During the COVID-19 Pandemic”.

In his lecture, Dr. Gandhi provided a comprehensive look at the many impacts of the pandemic on women’s health, including an increase in maternal mortality, limited access to family planning and abortion services, delays in gynecological surgeries, and a lack of access to COVID vaccinations for pregnant women. He stressed that the pandemic had resulted in women avoiding health facilities and highlighted the essential role of community health workers, midwives and telemedicine in addressing this challenge.

Learn more about FIGO’s pen surgery training initiative

Following this, the FIGO Committee for Fistulas and Genital Trauma organized a meeting on the FIGO Fistula Surgery training initiative. Gillian Slinger, Senior Project Manager of the FIGO initiative, started the session with an update on the initiative’s recent successes and future plans to expand the training program. Dr. Fekade Aneyachew Aklilu described the role of trainers in delivering fistula surgery training in resource-poor environments and the challenges one faces in becoming a trainer.

Dr. Hillary Mabeya then gave a presentation of advice for aspiring fistula surgery trainees and gave an insight into what to expect when training to become a fistula surgeon. Dr. Andrew Browning closed the session with a talk on persistent incontinence after fistula repair – with an emphasis on diagnosis, management and corrective surgery.

The meeting was rounded off by a discussion between Ms. Slinger and Dr. Mabeya on the importance of continuous training, the essential role of working with larger teams beyond surgeons, and the role FIGO has played in eradicating fistulas around the world.

Prenatal diagnostics

Later, the FIGO Maternal and Fetal Health Track organized a session on prenatal diagnostics. We first heard from Professor Lyn Chitty who gave a talk on rapid fetal exome sequencing for the diagnosis of monogenic conditions in fetuses with structural abnormalities. She focused on explaining what rapid fetal exome sequencing is, what it will deliver, and provided an overview of how it is currently being used in the UK NHS. Professor Svetlana Rechitsky focused on pre-implantation genetic testing (PGT-A) with Embryo Selection, in particular on the management of mosaic embryos.

Dr. James Goldberg spoke about advanced pre-conceptual vehicle screening, focusing on the medical history, recent changes to key guidelines and guidelines, and the clinical utility of these tests. Dr. Antoni Borrell concluded the session with a presentation on maternal plasma aneuploidy testing for all chromosomes, focusing mainly on cell-free DNA (cfDNA) testing.

Global Perspectives on Self-Administered Abortion

We then had an exciting live panel on “Spreading the Revolution – Why Investing in Self-Administered Abortions is the Way Forward to Realizing Women’s Right to Physical Autonomy”, led by Dr. Dorothy Shaw. The panel started with an introduction by Dr. Bela Ganatra on developing the World Health Organization’s recommendations on medical abortion over the past 20 years.

An exciting conversation followed between Dr. Shaw, Dr. Ganatra, Dr. Laura Gil, Professor Dame Lesley Regan, Mr. Shabin Shrestha and Ms. Jedidah Maina. The discussion focused on the main obstacles to self-directed abortion, namely the over-regulation of medical abortion, criminalization, social stigma and a lack of understanding of the issue.

The speakers shared valuable insights from around the world, used their platform to demand an approach that prioritizes listening to women and trusts them to know how to make decisions about their reproductive life. Speakers highlighted the key role of evidence in lobbying, improving access to information and training, removing barriers to access to safe abortion services, and appreciating the voices of people who have had experiences seeking abortion care.

End the day in Europe

The day ended with the Europe Regional Evening, organized by the European Board and College of Obstetrics and Gynecology (EBCOG), which started with a dedicated panel on the effects of COVID on OBGYN education in the region. We then heard from several speakers about examples of European learning fields. The evening ended with a conversation about OBGYN care for migrants in Europe. Each session of the evening was pleasantly ended with musical interludes by the renowned opera singer Danae Kontora, whose incredible voice could be heard at various points on the night of study.

Recordings of the entire meeting will be available on demand on the virtual congress platform within 24 hours.

To learn more about the congress or to register, visit www.figo2021.org.

Continue Reading

Women’s Health

Program focused on women vets health care could become mandatory for transitioning troops

Published

on

Following a proposal proposed by Congress to ensure women get the information they need about post-military health support services, transition into health care training could become a requirement for women service members leaving their ranks.

“It should be a compulsory program where female veterans can come together and talk about some of their problems in a safe place so that the Department of Defense and their military departments understand what their problems might be,” said Rep. Julia Brownley. D-California, on Tuesday.

“I think one of the problems is that women don’t even know about the program or have access to the program. And certainly, if it is not compulsory, you might miss it completely. “

TIED TOGETHER

Your comments came at a House Veterans Affairs Committee hearing on available support services for female troops and veterans.

As part of the discussion, panel members praised the transition to women’s health training program jointly run by VA and Defense Department officials over the past three years to provide more targeted information on post-military health care and support services.

But despite good reviews of the program so far, the panel’s lawmakers said they felt more needs to be done to promote it to ensure that female veterans are aware of it and have access to training.

Only about 37 percent of all female veterans in America are enrolled in VA health programs, according to a Congressional Research Service report earlier this year. For comparison: around half of all male veterans are enrolled in the system.

Health care officials have said that in transitioning from military life, it is critical to ensure veterans know and understand their available benefits – especially medical care – how to access them, and offer solutions to challenges such as financial problems, mental health issues, and thoughts of suicide .

Only about 1,500 female service workers have completed the Women’s Health Transitioning Training in recent years, which is currently a self-directed online course offered through the Transition Assistance Program. Of this group, 54 percent chose to enroll in VA health care after completing the course.

Lawrencia Pierce, assistant director of VA’s Office for Outreach, Transition and Economic Development, said officials plan to expand the program in the coming months to include virtual instructors to allow for greater engagement and feedback from course participants.

But William Mansell, director of the Defense Support Service Center, said officials hadn’t thought of making the course compulsory for women who are leaving the military because they prefer to keep the transition classes as flexible as possible to allow the transition forces be able to choose the training that best suits them needs.

“There are alternative avenues and different levels of support that allow service members to control their transition processes,” he said. “And if a changing service member states that they need this training, or if their self-assessment indicates that they need it, then they will get it.”

TIED TOGETHER

The Women in Military Service to America Memorial, the only national museum honoring military women, celebrated its 15th anniversary on October 20, 2012.

However, Browley and other lawmakers said this approach may not be strong enough, especially given the preconceived notion that VA health care is more focused on helping men than women.

“When women leave, they need to know what the options are,” she said. “And many of them leave on a traumatic basis. So many women are subjected to harassment or assault that happened to them during their military service. “

There are currently no pending laws on the matter, but Brownley indicated that if the expansion of training progresses slowly, she could begin creating such a plan.

Along with the addition of virtual coaches, Defense and VA officials said they plan to increase funding for the program in the coming months to allow for wider program visibility through existing programs and transition networks.

Leo covers Congress, Veterans Affairs, and the White House for Military Times. He has been reporting on Washington, DC since 2004, focusing on military personnel and veteran politics. His work has received numerous awards, including a 2009 Polk Award, a 2010 National Headliner Award, the IAVA Leadership in Journalism Award, and the VFW News Media Award.

Continue Reading
Advertisement

Trending